Lee, K., Zhang, Y., Guo, H., He, Z., Shi, J., Bao, Z., Abdrashitov, R., Zhang, Z., Bi, F. (2025). Final analysis of a multicenter, open-label, phase 2 study evaluating the efficacy and safety of tislelizumab (TIS) in combination with fruquintinib (F) in patients (pts) with selected solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2604